Stent versus drug balloon for heart artery blockages at branches
Part of Heart & circulation clinical trials.
This study compares two ways to treat blocked heart arteries at a branching point: placing a small metal mesh tube (stent) versus using only a special balloon coated with medicine. The goal is to see which approach keeps the artery open better and is safer for patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a blocked heart artery at a branch point that is new (not a previous stent failure).
- The blockage is in a major artery (but not the left main artery) and causes chest pain or evidence of reduced blood flow to the heart.
- The blocked section is less than 30 mm long, and the side branch is not too long or too blocked.
- You are 80 years old or younger, and your doctor expects you to live at least one more year.
- You have had a heart attack or unstable angina at least 3 months ago, but not in the last 3 months.
- You are not at high risk of bleeding, and you can take blood-thinning medications as prescribed.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two ways to treat a coronary artery blockage at a fork (bifurcation): one uses a standard stent, the other uses a special balloon that releases medication to keep the artery open. It aims to find which approach is safer and more effective for patients with this specific type of blockage.
This study tests a new type of heart stent against a special balloon treatment for people with a large, newly blocked heart artery. The goal is to see which treatment is safer and works better at keeping the artery open.
This study tests a balloon coated with sirolimus (a medicine to prevent re-narrowing) to treat blockages in branch arteries of the heart. It may help patients who need a stent in the main artery but have a side branch that can be treated with this balloon instead of a stent.
This trial compares two ways to open a specific type of heart blockage that involves both a main artery and a side branch. It tests whether using a drug-coated balloon (“hybrid strategy”) works as well as using a planned two-stent approach (“stepwise provisional strategy”).
This trial compares two treatments for new blockages in heart arteries: a drug-coated balloon (a tiny balloon that delivers medicine) versus a drug-eluting stent (a small mesh tube that releases medicine). The study hopes to see which approach keeps the artery open longer and is safer over time.
This trial compares two ways to open blocked heart arteries: a drug-coated balloon (a small balloon that releases medicine) versus a drug-eluting stent (a tiny mesh tube that also releases medicine). It aims to find which option works better for people with relatively simple blockages.
Hear when a new Coronary Bifurcation Lesion trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.